These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23962393)

  • 1. Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.
    Villano M; Borghini A; Manetti M; Gabbrielli E; Rossi A; Sestini P; Milia A; Nacci F; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
    Arthritis Res Ther; 2013 Aug; 15(4):R90. PubMed ID: 23962393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen.
    Lemaire R; Farina G; Kissin E; Shipley JM; Bona C; Korn JH; Lafyatis R
    Arthritis Rheum; 2004 Mar; 50(3):915-26. PubMed ID: 15022335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human microvascular lymphatic and blood endothelial cells produce fibrillin: deposition patterns and quantitative analysis.
    Rossi A; Gabbrielli E; Villano M; Messina M; Ferrara F; Weber E
    J Anat; 2010 Dec; 217(6):705-14. PubMed ID: 21039476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma).
    Wallis DD; Tan FK; Kielty CM; Kimball MD; Arnett FC; Milewicz DM
    Arthritis Rheum; 2001 Aug; 44(8):1855-64. PubMed ID: 11508439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.
    Borghini A; Manetti M; Nacci F; Bellando-Randone S; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
    PLoS One; 2015; 10(6):e0130166. PubMed ID: 26076019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies.
    Ahmed SS; Tan FK; Arnett FC; Jin L; Geng YJ
    Arthritis Rheum; 2006 Jul; 54(7):2250-62. PubMed ID: 16802364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pattern of fibrillin deposition correlates with microfibril-associated glycoprotein 1 (MAGP-1) expression in cultured blood and lymphatic endothelial cells.
    Weber E; Rossi A; Solito R; Aglianò M; Sacchi G; Gerli R
    Lymphology; 2004 Sep; 37(3):116-26. PubMed ID: 15560107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the "scleroderma phenotype".
    Zhou X; Tan FK; Milewicz DM; Guo X; Bona CA; Arnett FC
    J Immunol; 2005 Oct; 175(7):4555-60. PubMed ID: 16177099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal tissue and cellular expression of fibrillin-1 in diffuse cutaneous systemic sclerosis.
    Wipff J; Avouac J; Le Charpentier M; Varret M; Houtteman A; Ruiz B; Vacher-Lavenu MC; Kahan A; Boileau C; Allanore Y
    Rheumatology (Oxford); 2010 Apr; 49(4):657-61. PubMed ID: 20081226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosis.
    Lemaire R; Bayle J; Lafyatis R
    Curr Opin Rheumatol; 2006 Nov; 18(6):582-7. PubMed ID: 17053502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta.
    Massam-Wu T; Chiu M; Choudhury R; Chaudhry SS; Baldwin AK; McGovern A; Baldock C; Shuttleworth CA; Kielty CM
    J Cell Sci; 2010 Sep; 123(Pt 17):3006-18. PubMed ID: 20699357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
    Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAGP-2 has multiple binding regions on fibrillins and has covalent periodic association with fibrillin-containing microfibrils.
    Hanssen E; Hew FH; Moore E; Gibson MA
    J Biol Chem; 2004 Jul; 279(28):29185-94. PubMed ID: 15131124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation.
    Kissin EY; Lemaire R; Korn JH; Lafyatis R
    Arthritis Rheum; 2002 Nov; 46(11):3000-9. PubMed ID: 12428243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfibril-associated glycoprotein-2 (MAGP-2) is specifically associated with fibrillin-containing microfibrils but exhibits more restricted patterns of tissue localization and developmental expression than its structural relative MAGP-1.
    Gibson MA; Finnis ML; Kumaratilake JS; Cleary EG
    J Histochem Cytochem; 1998 Aug; 46(8):871-86. PubMed ID: 9671438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.
    Gerber EE; Gallo EM; Fontana SC; Davis EC; Wigley FM; Huso DL; Dietz HC
    Nature; 2013 Nov; 503(7474):126-30. PubMed ID: 24107997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of type I collagen induced by microfibril-associated glycoprotein 2: novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma.
    Lemaire R; Korn JH; Shipley JM; Lafyatis R
    Arthritis Rheum; 2005 Jun; 52(6):1812-23. PubMed ID: 15934076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study.
    Romano E; Bellando-Randone S; Manetti M; Bruni C; Lepri G; Matucci-Cerinic M; Guiducci S
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S148-52. PubMed ID: 26088817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Rosa I; Ceccarelli C; Mello T; Milia AF; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Rheum; 2013 Jan; 65(1):247-57. PubMed ID: 23001478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.